HUTCHMED (China) (HCM) Liabilities and Shareholders Equity (2016 - 2025)

Historic Liabilities and Shareholders Equity for HUTCHMED (China) (HCM) over the last 11 years, with Q2 2025 value amounting to $1.8 billion.

  • HUTCHMED (China)'s Liabilities and Shareholders Equity rose 4085.06% to $1.8 billion in Q2 2025 from the same period last year, while for Jun 2025 it was $166.9 billion, marking a year-over-year increase of 610557.09%. This contributed to the annual value of $163.3 billion for FY2024, which is 9970443805.04% up from last year.
  • HUTCHMED (China)'s Liabilities and Shareholders Equity amounted to $1.8 billion in Q2 2025, which was up 4085.06% from $163.9 billion recorded in Q4 2024.
  • In the past 5 years, HUTCHMED (China)'s Liabilities and Shareholders Equity registered a high of $163.9 billion during Q4 2024, and its lowest value of $163786.0 during Q4 2023.
  • Over the past 5 years, HUTCHMED (China)'s median Liabilities and Shareholders Equity value was $1.3 billion (recorded in 2021), while the average stood at $17.3 billion.
  • In the last 5 years, HUTCHMED (China)'s Liabilities and Shareholders Equity plummeted by 9987.55% in 2023 and then surged by 10007012940.4% in 2024.
  • HUTCHMED (China)'s Liabilities and Shareholders Equity (Quarter) stood at $1.3 billion in 2021, then tumbled by 89.91% to $131.6 million in 2022, then plummeted by 99.88% to $163786.0 in 2023, then soared by 100070129.4% to $163.9 billion in 2024, then crashed by 98.92% to $1.8 billion in 2025.
  • Its Liabilities and Shareholders Equity stands at $1.8 billion for Q2 2025, versus $163.9 billion for Q4 2024 and $1.3 billion for Q2 2024.